Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Filter Results By

Filter Applied. Clear All
Reset All Filters
Scholar

Eugene C. Tarne

Senior Analyst

Eugene C. Tarne is a senior analyst with the Charlotte Lozier Institute. He is also the president of Tarne Communications Inc., a communications and issue advocacy company he founded in 1999. For more than 25 years, beginning in 1989, Mr. Tarne served as a communications and media relations consultant to the United States Conference of Catholic Bishops Secretariat for Pro-Life Activities. In this capacity, he works closely with the Pro-Life Secretariat to develop messages, promote issues and legislation, develop new programs and materials and implement communications strategies designed to educate the public and promote pro-life issues in the public square. These issues include abortion, assisted suicide and euthanasia, and bioethical issues, especially cloning and stem cell research. In 1996, Mr. Tarne helped found the Physicians Ad Hoc Coalition for Truth (PHACT), an organization of doctors and other medical professionals formed to bring the medical facts to bear on the partial-birth abortion debate. Mr. Tarne also served as Communications Director for Do No Harm: The Coalition of Americans for Research Ethics, a coalition of scientists, researchers, bioethicists, medical, academic and other professionals, patient advocates, and concerned individuals, established in 1999, to promote the ethical pursuit of stem cell research and regenerative medicine in general, and to provide accurate information on such research. Mr. Tarne graduated from Georgetown University in 1977 with a B.A. in Theology. He received his M.A. in History of Religions from The George Washington University in 1979. He was offered scholarships to Harvard, the University of Chicago and the University of Pennsylvania to pursue a Ph.D. in South Asian Studies. He attended the University of Chicago and later the University of Pennsylvania, where he completed his Ph.D. studies, except for dissertation.

Research Authored

featured-image
Fetal Tissue, Stem Cells & Bioethics

Ethical Stem Cells Provide Model for Progress in Down Syndrome Research

Researchers using ethically uncontroversial induced pluripotent stem cells (iPSCs) have achieved what appears to be a major breakthrough in understanding the origin and development of Down syndrome, according to a new study recently published in Nature Communications.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Cloning is Cloning is Cloning

This primer on cloning examines the nature and purpose of human cloning in light of recent developments in stem cell technology. The paper points out that all cloning is reproductive and reflects on the immediate outcome of human cloning - a human embryo - while examining the terminology used by cloning advocates to obscure the facts.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Maryland Joins the Trend for Ethical Stem Cell Research

This paper continues the investigation of stem cell research funding in the United States by examining the funding patterns at the Maryland Stem Cell Research Commission. This investigation reveals that the Maryland Commission is keeping with the trend of investing more money in ethical stem cell research as opposed to embryonic as it is this route which is providing demonstrable results.

featured-image
Abortion

Ideas Have Consequences

The horrors revealed at the trial of Philadelphia abortionist Kermit Gosnell have put abortion advocates in a defensive pose.

featured-image
Fetal Tissue, Stem Cells & Bioethics

New California Grants Once Again Bolster Ethical Stem Cell Alternatives

The most recent round of grants by the California Institute for Regenerative Medicine (CIRM) demonstrates – again – where the future of stem cell research lies.

featured-image
Fetal Tissue, Stem Cells & Bioethics

UK Government Panel Approves Genetically Engineered “Three-Parent” Embryos

Great Britain’s Human Fertilisation and Embryology Authority (HFEA), which oversees fertility treatments and embryo research in that nation, recently approved fertility procedures that would amount to the genetic engineering of children through cloning (nuclear transfer) technology and germ-line modification, resulting in a “three-parent embryo” that would have genetic material from two mothers and one father.

featured-image
Life & the Law

Justice Not Sought for Unborn Victims of Violence

A recent pretrial hearing of Fort Hood shooter Major Nidal Hasan provides the opportunity to again raise the question as to why prosecutors are not seeking justice for all the victims of the 2009 massacre.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Major Step Forward for Ethical Stem Cell Research

A major New England biotech company recently announced that it would begin the process that it hopes will result in the first clinical trial using induced pluripotent stem cells (iPSCs).

featured-image
Fetal Tissue, Stem Cells & Bioethics

The Ethical Stems of Good Science

This paper examines the funding pattern of the California Institute for Regenerative Medicine, an institution which characterizes itself as the “largest source of funding for stem cell research outside the NIH.” Tarne demonstrates that funding has moved from grants directed primarily towards embryonic stem cell research toward primarily ethical stem cells research - which has been the only stem cell research to date to result in positive treatments for illnesses.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Possible Adult Stem Cell Therapy for Blood-Disorders in Down Syndrome

A recent study from researchers at the University of Washington announced a major step forward in the treatment of genetic diseases and specifically in treating Down syndrome patients.